Taimur T Shah, Abi Kanthabalan, Marjorie Otieno, Menelaos Pavlou, Rumana Omar, Sola Adeleke, Francesco Giganti, Chris Brew-Graves, Norman R Williams, Jack Grierson, Haroon Miah, Amr Emara, Athar Haroon, Arash Latifoltojar, Harbir Sidhu, Joey Clemente, Alex Freeman, Clement Orczyk, Ashok Nikapota, Tim Dudderidge, Richard G Hindley, Jaspal Virdi, Manit Arya, Heather Payne, Anita Mitra, Jamshed Bomanji, Mathias Winkler, Gail Horan, Caroline M Moore, Mark Emberton, Shonit Punwani, Hashim U Ahmed
BACKGROUND: Recurrent prostate cancer after radiotherapy occurs in one in five patients. The efficacy of prostate magnetic resonance imaging (MRI) in recurrent cancer has not been established. Furthermore, high-quality data on new minimally invasive salvage focal ablative treatments are needed. OBJECTIVE: To evaluate the role of prostate MRI in detection of prostate cancer recurring after radiotherapy and the role of salvage focal ablation in treating recurrent disease...
June 2022: European Urology